First Biosimilar of Inhalation Solution for Cystic Fibrosis Treatment Approved

被引：0
|
作者：
不详
机构：
来源：
BIOPHARM INTERNATIONAL | 2019年 / 32卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：13 / 13
页数：1
相关论文
共 50 条
  • [21] Approved indication: cystic fibrosis
    不详
    [J]. AUSTRALIAN PRESCRIBER, 2021, 44 (04) : 137 - 138
  • [22] Levofloxacin inhalation solution for the treatment of chronic Pseudomonas aeruginosa infection among patients with cystic fibrosis
    Stockmann, Chris
    Hillyard, Brad
    Ampofo, Krow
    Spigarelli, Michael G.
    Sherwin, Catherine M. T.
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (01) : 13 - 22
  • [23] Aztreonam inhalation solution for suppressive treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis
    Assael, Baroukh Maurice
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (11) : 967 - 973
  • [24] Bevacizumab-awwb becomes first biosimilar approved for cancer treatment
    Abraham, Jame
    [J]. JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2018, 16 (02): : E60 - E62
  • [25] Bronchitol has been approved in the EU for the treatment of cystic fibrosis
    Attwood, Claire
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2012, 6 (03) : 249 - 249
  • [26] Inhalation therapy in cystic fibrosis
    Battistini, A
    [J]. RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1998, 24 (02): : 100 - 102
  • [27] EFFECT OF TOBRAMYCIN INHALATION SOLUTION ON MORTALITY IN SUBGROUPS OF PATIENTS WITH CYSTIC FIBROSIS
    Latremouille-Viau, D.
    Sawicki, G. S.
    Zhang, J.
    von Wartburg, M.
    Signorovitch, J.
    Wu, E. Q.
    Shi, L.
    [J]. PEDIATRIC PULMONOLOGY, 2011, : 346 - 346
  • [28] Aztreonam lysine for inhalation solution: a guide to its use in cystic fibrosis
    [J]. Drugs & Therapy Perspectives, 2011, 27 (4) : 1 - 4
  • [29] Population Pharmacokinetics of Tobramycin Inhalation Solution in Pediatric Patients With Cystic Fibrosis
    Wang, Xinting
    Koehne-Voss, Stephan
    Anumolu, SivaNaga S.
    Yu, Jing
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (11) : 3402 - 3409
  • [30] Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution
    Sawicki, Gregory S.
    Signorovitch, James E.
    Zhang, Jie
    Latremouille-Viau, Dominick
    von Wartburg, Markus
    Wu, Eric Q.
    Shi, Lizheng
    [J]. PEDIATRIC PULMONOLOGY, 2012, 47 (01) : 44 - 52
12345